Memorial Sloan Kettering start-up lands $25M investment for its AI-based approach to cancer pathology

A spinoff from Memorial Sloan Kettering (MSK) in New York has closed $25 million in Series A funding to commercialize its AI-based approach to cancer pathology. Launched by MSK researchers Thomas Fuchs and David Kilmstra, Paige.AI has also signed a deal with MSK Cancer to have exclusive access to 25 …read more

Written by

No Comments Yet.

Leave a Reply

Message

CommentLuv badge